Pulmonary vein reconnections or substrate in the left atrium: what is the reason for atrial fibrillation recurrences? A dialogue on a pressing clinical situation
- PMID: 30801129
- DOI: 10.1093/europace/euy289
Pulmonary vein reconnections or substrate in the left atrium: what is the reason for atrial fibrillation recurrences? A dialogue on a pressing clinical situation
Abstract
Pulmonary vein isolation (PVI) has long been held as the cornerstone for atrial fibrillation (AF) ablation. There are patients who do not have successful AF ablations though, especially among those with persistent AF. At the same time, the evidence suggests that ablating beyond the pulmonary veins does not improve success rates. Two possibilities for the incomplete success rates from the procedure are discussed: that more attention needs to be paid to PVI, optimizing delivery of durable, transmural lesions; or alternatively, shifting the focus away from just PVI and addressing the left atrial substrate itself. These two approaches are likely complementary though, and high-density mapping may offer us the ability to undertake them more effectively. The conclusion from this dialogue is that AF is a heterogenous disease and key is to recognize this heterogeneity and respond to it, rather than have a standardized, dogmatic approach. Durable PVI is clearly an important determinant of success but concurrently, we would suggest we need to go beyond this where appropriate to maximize success rates. Clearly the challenge is defining which patients this is appropriate for and how best to do this. Consequently, rather than being 'the' cornerstone of AF ablation, it is more appropriate to consider PVI as 'a' cornerstone of the procedure going forwards and high-density mapping may be the key to optimizing both aspect of the procedure and in so doing improve long term success rates.
Keywords: Ablation; Atrial fibrillation; Efficacy; High-density mapping; LA substrate; Pulmonary vein isolation.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Long-Term Outcome of Left Atrial Voltage-Guided Substrate Ablation During Atrial Fibrillation: A Novel Adjunctive Ablation Strategy.J Cardiovasc Electrophysiol. 2017 Feb;28(2):147-155. doi: 10.1111/jce.13122. Epub 2016 Dec 14. J Cardiovasc Electrophysiol. 2017. PMID: 27862561
-
Efficacy of Left Atrial Voltage-Based Catheter Ablation of Persistent Atrial Fibrillation.J Cardiovasc Electrophysiol. 2016 Sep;27(9):1055-63. doi: 10.1111/jce.13019. Epub 2016 Jun 30. J Cardiovasc Electrophysiol. 2016. PMID: 27235000
-
Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.Heart Rhythm. 2016 Feb;13(2):399-406. doi: 10.1016/j.hrthm.2015.10.006. Epub 2015 Oct 9. Heart Rhythm. 2016. PMID: 26455343 Clinical Trial.
-
Reasons for successful clinical outcome following pulmonary vein isolation despite lack of persistent LA-PV conduction block.Pacing Clin Electrophysiol. 2019 Jul;42(7):1056-1062. doi: 10.1111/pace.13732. Epub 2019 Jun 4. Pacing Clin Electrophysiol. 2019. PMID: 31116439 Review.
-
Catheter Ablation of Paroxysmal Atrial Fibrillation: Have We Achieved Cure with Pulmonary Vein Isolation?Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):71-5. doi: 10.14797/mdcj-11-2-71. Methodist Debakey Cardiovasc J. 2015. PMID: 26306122 Free PMC article. Review.
Cited by
-
Comparison of lesion characteristics between conventional and high-power short-duration ablation using contact force-sensing catheter in patients with paroxysmal atrial fibrillation.BMC Cardiovasc Disord. 2021 Aug 9;21(1):387. doi: 10.1186/s12872-021-02196-y. BMC Cardiovasc Disord. 2021. PMID: 34372779 Free PMC article.
-
Long-Term Impact of Additional Ablation After Pulmonary Vein Isolation: Results From EARNEST-PVI Trial.J Am Heart Assoc. 2023 Sep 5;12(17):e029651. doi: 10.1161/JAHA.123.029651. Epub 2023 Aug 29. J Am Heart Assoc. 2023. PMID: 37642022 Free PMC article. Clinical Trial.
-
Concise Guidelines of the European Cardiac Arrhythmias Society (ECAS) on "Catheter Ablation of Atrial Fibrillation".J Cardiovasc Electrophysiol. 2025 May;36(5):1076-1099. doi: 10.1111/jce.16561. Epub 2025 Mar 4. J Cardiovasc Electrophysiol. 2025. PMID: 40035661 Free PMC article. No abstract available.
-
Evaluation of Isolation Area, Myocardial Injury and Left Atrial Function Following High-Power Short-Duration Radiofrequency or Second-Generation Cryoballoon Ablation for Atrial Fibrillation.J Cardiovasc Dev Dis. 2022 Sep 28;9(10):327. doi: 10.3390/jcdd9100327. J Cardiovasc Dev Dis. 2022. PMID: 36286279 Free PMC article.
-
Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillation.PLoS One. 2022 Apr 25;17(4):e0264894. doi: 10.1371/journal.pone.0264894. eCollection 2022. PLoS One. 2022. PMID: 35468171 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical